Review: Systematic review of the utility of the fetal cerebroplacental ratio measured at term for the prediction of adverse perinatal outcome by Dunn, Liam et al.
Accepted Manuscript
Review: Systematic review of the utility of the fetal cerebroplacental ratio measured at
term for the prediction of adverse perinatal outcome
Liam Dunn, Helen Sherrell, Sailesh Kumar
PII: S0143-4004(17)30149-2
DOI: 10.1016/j.placenta.2017.02.006
Reference: YPLAC 3577
To appear in: Placenta
Received Date: 4 December 2016
Revised Date: 2 February 2017
Accepted Date: 7 February 2017
Please cite this article as: Dunn L, Sherrell H, Kumar S, Review: Systematic review of the utility of the
fetal cerebroplacental ratio measured at term for the prediction of adverse perinatal outcome, Placenta
(2017), doi: 10.1016/j.placenta.2017.02.006.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Systematic review of the utility of the fetal cerebroplacental ratio measured at term for the 1 
prediction of adverse perinatal outcome. 2 
Liam Dunn
1
, Helen Sherrell
1
, Sailesh Kumar
1,2,3
 3 
1 – Mater Research Institute – University of Queensland, Brisbane 4 
2 – Mater Health Service, Brisbane 5 
3 – School of Medicine, University of Queensland, Brisbane 6 
 7 
Study location: Mater Mothers’ Hospital, Brisbane, Australia. Funding source: LD receives a 8 
University of Queensland Research Stipend. LD and HS receive scholarships through Mater Research 9 
Institute-University of Queensland. The authors report no conflicts of interest. 10 
Title (short version): Cerebroplacental ratio at term: a systematic review. 11 
Keywords: cerebroplacental ratio; Dopplers; perinatal outcomes; 12 
 13 
 14 
Corresponding author:  15 
Professor Sailesh Kumar 16 
Mater Research Institute – University of Queensland 17 
Level 3, Aubigny Place, Raymond Terrace 18 
South Brisbane, Queensland, Australia, 4101 19 
Email: sailesh.kumar@mater.uq.edu.au 20 
Phone: +617 3163 8844 21 
 22 
 23 
 24 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Abstract 25 
Aim  26 
This systematic review evaluates the utility of the fetal cerebroplacental ratio (CPR) when assessed 27 
at term (from 37+0 weeks gestation) as a predictor of adverse obstetric and perinatal outcomes.  28 
Data sources and search strategy  29 
An electronic search of Pubmed and Embase using variations of ‘cerebroplacental ratio’ and 30 
‘cerebroumbilical ratio’ was conducted by two independent reviewers. Full text studies written in 31 
English that reported on low CPR and its correlation with relevant obstetric and perinatal outcomes 32 
were included. 33 
Results 34 
Twenty one studies satisfied inclusion with 13 prospective and eight retrospective analyses. Fetal 35 
CPR was predictive of caesarean section for intrapartum fetal compromise, small for gestational age 36 
and fetal growth restriction and neonatal intensive care unit admission. Low CPR was also 37 
significantly associated with abnormal fetal heart rate pattern, meconium stained liquor, low Apgar 38 
score, acidosis at birth and composite adverse perinatal outcome scores. The CPR when taken at 39 
term had comparable if not better predictive value than that when taken at pre-term. Most studies 40 
included small for gestational age fetuses and postdate pregnancies. Subtle variation existed in the 41 
threshold for low CPR.  42 
Conclusion 43 
The CPR at term has a strong association with adverse obstetric and perinatal outcomes. This review 44 
suggests the predictive utility of CPR at term is promising however there is insufficient evidence to 45 
demonstrate its value as a stand-alone test. Inclusion of CPR as a component of clinical care may 46 
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help better identify fetuses at risk of adverse outcome, and this should be tested with randomised 47 
control trials.  48 
 49 
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INTRODUCTION 1 
For the majority of pregnancies, the placenta provides adequate metabolic and oxygen supply to the 2 
fetus through to birth without any detrimental effects on growth or wellbeing. However, when 3 
placental function is suboptimal impaired fetal growth can supervene. In late pregnancy, this is a 4 
major risk factor for stillbirth and other adverse obstetric and perinatal outcomes [1-3]. For the 5 
neonate, there is also a much greater likelihood of longer term neurological and 6 
neurodevelopmental morbidity[4-6], as well as cardiovascular disease and other metabolic 7 
conditions later in life[7-10]. There is also evidence that even in a cohort of fetuses that are 8 
appropriately grown (AGA) with estimated weights above the 10th centile, some demonstrate 9 
circulatory changes consistent to that seen in a fetus with obvious growth restriction. These AGA 10 
fetuses are also at increased risk of adverse obstetric and perinatal outcomes[11-14].  11 
The fetal cerebroplacental ratio (CPR) is the ratio of the fetal middle cerebral artery (MCA) pulsatility 12 
index (PI) to umbilical artery (UA) PI. It is believed to be a proxy for suboptimal fetal growth[15, 16] 13 
given it quantifies both suboptimal placental function and subsequent fetal circulatory 14 
adaptations[17]. It is believed that the CPR better predicts adverse perinatal outcomes than its 15 
individual components[18-23] and better than conventional anthropometric models[13].  16 
OBJECTIVE 17 
The aim of this systematic review was to evaluate the utility of CPR when assessed at term (≥37+0 18 
weeks) as a predictor for adverse perinatal outcomes. 19 
DATA SOURCES AND METHODOLOGY 20 
An online database search of PubMed and Embase for all relevant publications from the past 30 21 
years was undertaken by the authors and institutional research librarian in September 2016. Search 22 
terms were variations of ‘cerebroumbilical ratio’ and ‘cerebroplacental ratio’.  23 
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The population of interest was pregnant women who had a CPR evaluated from 37+0 – 42+0 weeks 24 
gestational age compared to those with normal CPR or a control group as described by the authors. 25 
Studies were eligible for inclusion if they reported relevant obstetric and perinatal outcomes and 26 
their association with the CPR (regardless of blinding).  27 
An initial title and abstract review was conducted on all publications from the search to exclude 28 
duplicated and ineligible manuscripts. A revised short-list of full-text manuscripts written in English 29 
that were available electronically were then reviewed in detail. A manual search of the reference 30 
lists of short-listed articles was also carried out to identify relevant articles not captured in the initial 31 
electronic searches. These reviews were conducted independently by authors LD and HS. 32 
Systematic and expert reviews, case series and reports, abstracts, book chapters, opinion pieces and 33 
guidelines were excluded. Publications were also excluded if they investigated the influence of an 34 
intervention on the CPR. Relevant standards of reporting for each publication type[24] were 35 
referenced, as was the Preferred Reporting for Systematic Reviews and Meta-Analyses 36 
statement[25]. 37 
RESULTS 38 
The flow of identification of relevant studies is shown in Figure 1. Four hundred and seventeen 39 
publications were initially retrieved using the abovementioned methodology and 31 full text articles 40 
were then reviewed. The final number of eligible manuscripts was 21 and includes 13 prospective 41 
observational[11, 14, 16, 23, 26-34] and eight retrospective[12, 13, 15, 35-40] studies.  42 
Data on maternal and fetal characteristics, number of participants that had a CPR evaluated, 43 
individual CPR components and abnormal CPR cut off threshold, gestational age at which the CPR 44 
was obtained and CPR to delivery interval are presented in Table 1. Obstetric (mode of, and 45 
indication for birth, meconium stained liquor (MSL), fetal heart rate (FHR) abnormalities) and 46 
perinatal (birthweight, Apgar scores, acidosis at birth, neonatal intensive care unit (NICU) admission) 47 
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outcomes are presented in Table 2. Sensitivities, specificities, negative predictive values (NPV), 48 
positive predictive values (PPV) and other predictive ratios for various outcomes are presented in 49 
Table 3. Not all outcomes relevant to this review were reported by each publication. 50 
There was lack of uniformity in the Doppler indices used to construct the CPR. Most studies used the 51 
MCA-PI/UA-PI ratio[11, 13-16, 26-31, 35, 37], although S/D[23] and RI[36, 38, 39] ratios were also 52 
reported, mainly in earlier studies. The threshold that described an abnormal CPR varied between 53 
studies including <5th centile[14, 28, 35, 37], <10th centile[11, 14] and values <0.90[37], ≤1[14], 54 
<1.05[23, 27], <1.09[30] <1.1[29, 36, 38, 39], <1.3[29] and <0.6765MoM[13, 15, 16, 35]. Not all 55 
included studies however reported an abnormal CPR value and there was wide variation in the 56 
characteristics of the control group across studies. There was also variation in the terminology used 57 
to describe fetal/neonatal size. Some studies defined small for gestational age (SGA) as birthweight 58 
(BW) <10th centile[12, 13, 15, 26, 35, 39] whilst others used estimated fetal weight (EFW) <10th 59 
centile[16, 28, 30, 32, 33]. Fetal growth restriction (FGR) was variously defined as BW <3rd centile[26] 60 
with abnormal fetal Dopplers[15], EFW <3rd centile with abnormal UA-PI[16] and as BW <10th centile 61 
with abnormal MCA-PI[40]. Appropriate for gestational age (AGA) was defined as BW[13, 35] or 62 
EFW[16] >10th – 90th centiles. Other studies did not clearly define these terms[11, 14, 23, 27, 29, 31, 63 
36, 37].  64 
The CPR-to-delivery interval varied from ≤24 hours[28, 36, 38] to ≤14 days[13-15, 35] and most 65 
studies reported clinicians being blinded to CPR data[11, 14, 16, 23, 26, 28-31, 35, 39]. 66 
The majority of studies had broadly similar exclusion criteria (e.g. significant maternal conditions, 67 
fetal anomalies, intrauterine fetal death and stillbirth) in an attempt to create relatively normal or 68 
low risk cohorts. Furthermore, assessment criteria of IFC (e.g. FHR pattern, fetal blood sampling), 69 
and neonatal outcomes (e.g. Apgar <7 at one and five minutes, acidosis at birth [UA pH<7.2, base 70 
excess (BE) >12mEq/L], NICU admission) was very similar across studies.  71 
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Obstetric Outcomes 72 
Mode of Birth 73 
The association of low CPR and mode of birth was reported in nine studies[11, 12, 14, 16, 27, 28, 33, 74 
36, 40]. An abnormal CPR, as defined in each study, was associated with an overall increased for 75 
birth by emergency caesarean (CS)[27, 28, 33, 36, 40]. In particular, the CPR was shown to be an 76 
independent predictor of CS for intrapartum fetal compromise (CS-IFC), with an area under the 77 
receiver operator characteristic curve (AUROC) of 0.69 [11]. An abnormal CPR had a six- (OR 6.1, 95% 78 
CI 3.03-12.75)[11] to 10-fold (OR 10.3 95%CI 3.22-52.8)[28] increased odds of CS-IFC. Khalil et al. 79 
2015[12], also described the association of low CPR with both instrumental delivery for IFC as well as 80 
CS-IFC, with the CPR being an independent predictor any operative delivery for IFC, irrespective of 81 
fetal size. Conversely, a normal CPR was more likely to be associated with SVD[14, 16, 27]. Birth by 82 
SVD was up to three times more likely in the setting of a normal CPR (OR 2.93 95%CI 1.41-6.13)[11].  83 
Abnormal Fetal Heart Rate Pattern 84 
Four studies[11, 16, 36, 39] reported that a low CPR was associated with FHR abnormalities (40.8% v 85 
18.5%[16], 62.3% v 19.0%[36] and 86% v 28.9%[11]; all p<0.05) and that the likelihood of the having 86 
an abnormal FHR was increased more than two fold with a low CPR[16, 36]. One study also showed 87 
that at a CPR threshold of 1.1 had higher sensitivity and NPV for abnormal FHR patterns than either 88 
the MCA or UA Doppler indices individually[36]. 89 
Meconium Stained Liquor 90 
Meconium stained liquor (MSL) was reported in four studies[11, 16, 30, 36]. Lam et al. 2005[30] did 91 
not demonstrate any correlation between a low CPR and MSL, whereas three other studies[11, 16, 92 
36] reported a higher prevalence of MSL amongst the low CPR cohort. In these studies, the rates of 93 
MSL ranged from 22.4%[16] to 46.4%[36] and the likelihood of MSL in the setting of a low CPR was 94 
nearly two-fold greater (RR1.96, 95% CI 1.12-3.43, p=0.03)[16]. 95 
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Perinatal Outcomes 96 
Birthweight 97 
The association of birthweight, SGA and FGR with CPR was reported by 11 studies[11, 13, 15, 16, 26, 98 
30, 32, 33, 35, 36, 40]. Lower median and mean birthweights was associated with low a CPR in six 99 
studies[13, 16, 33, 35, 36, 40] though one study reported no difference in mean birthweights across 100 
CPR centiles[11]. The latter study along with two others[15, 16] did however report a significant 101 
correlation between CPR and birthweight centiles, with higher birthweight centiles reported in the 102 
normal CPR cohort[11]. Even amongst AGA cohorts, those with lower birthweights had a significantly 103 
lower CPR[13, 15, 16, 35]. A low CPR was consistently reported to correlate with the presence of 104 
both SGA[26, 30, 32, 36] and FGR[26, 33] births. Triunfo et al. 2016[26], reported that the CPR z-105 
score was an independent predictor of both SGA (Detection Rate [DR] 13.7, 10% false positive 106 
rate[FPR]) and FGR (DR 27.8, 10% FPR), with corresponding AUROC values of 0.56 and 0.65 107 
respectively[26]. However, whilst the CPR performed better than other Doppler indices in this study, 108 
it did not out-perform EFW for either SGA or FGR (DR 59.2, 10% FPR and 83.3%, 10% FPR, 109 
respectively)[26].  110 
Low Apgar Score 111 
There were four studies[11, 16, 36, 40] that reported the relationship between the CPR and Apgar 112 
scores. Prior et al. 2015[16], reported that Apgar scores <7 at both one minute (56.5% v 5.1% 113 
p<0.001) and five minutes (27.5% v 1.3%, p<0.001) were significantly lower with a low pre-labour 114 
CPR. Another two studies[11, 16] reported a greater frequency of poor Apgar scores in the low CPR 115 
group, but these did not reach significance. In a further study[40], no poor Apgar scores were 116 
observed irrespective of the CPR.  117 
Acidosis at Birth 118 
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Ten studies[11, 13, 16, 23, 28, 31, 33, 35, 36, 40] described the results of cord blood analysis. 119 
Ropacka-Lesiak et al. 2015[36], reported that neonates born in the low CPR cohort were more likely 120 
to have acidosis compared to normal CPR controls. The differences were significant across each 121 
parameter: UA pH<7.2 (39.1% v 2.5%), base excess <-12mEq/L (34.8% v 5.1%), pO2 <15mmHg 122 
(43.5% v 24.0%) and pCO2 >45mmHg (44.9% v 16.5%) (all p<0.05). Two other studies also reported 123 
that low CPR was associated with cord blood acidosis[13, 33] and one reported that the CPR 124 
correlated better than birthweight cord blood acidosis[13]. Cruz-Martinez et al. 2011[28], described 125 
that SGA fetuses with an abnormal CPR had a five-fold likelihood of cord blood acidaemia (OR 5.0, 126 
95%CI 1.06-46.9). Other studies did not demonstrate a significant relationship between abnormal 127 
CPR and abnormal cord blood analysis[11, 16, 31].  128 
Admission to Neonatal Intensive Care Unit 129 
Admission to NICU was reported in five studies[11, 12, 16, 33, 40]. Between 21.9%[40] and 130 
37.1%[33] of fetuses with an EFW<10th centile and an abnormal CPR required admission to NICU – 131 
rates significantly higher compared to normal CPR cohorts (11.1%[40] to 21.3%[33]). Irrespective of 132 
fetal size, a low CPR was independently associated with NICU admission (aOR 0.55, 95%CI 0.33-0.92, 133 
p<0.021), outperforming that of birthweight centile (aOR 1.00, 95%CI 0.99-1.00, p0.794)[12]. Two 134 
further studies reported higher NICU admission rates amongst abnormal CPR cohorts but these did 135 
not reach significance[11, 16]. 136 
Composite Adverse Perinatal Outcome 137 
Composite adverse perinatal outcomes and their association with CPR were reported in 11 138 
studies[11, 16, 23, 26, 27, 29, 32-34, 36, 37]. Outcome variables included in the composite included 139 
CS-IFC, cord blood acidosis, poor Apgar scores and NICU admission. Low CPR resulted in a more than 140 
two-fold increase in the likelihood of adverse perinatal outcomes (OR 2.43, 95%CI 1.28-4.59)[33] and 141 
had better sensitivity (87.8%) and NPV (93.7%) than MCA and UA Dopplers[36] as well as other tests 142 
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including amniotic fluid index, biophysical profile and non-stress test[23]. Triunfo et al. 2016[26], 143 
reported that the CPR had a detection rate of 23.1% (10% FPR) for composite adverse perinatal 144 
outcome which was more reliable than EFW (DR 19.2%), umbilical venous blood flow (DR 16.9%) and 145 
uterine artery Dopplers (DR 9.2%). The AUROC for CPR predicting adverse perinatal outcomes was 146 
0.52 (0.44-0.59)[27]. In two studies[32, 33] more than half of the low CPR fetuses had adverse 147 
perinatal outcomes (50.7% v 6.3%[36]; 57.3% v 34.7%[33] respectively, p<0.05) and in another study 148 
more than one third (37.5% v 19.1%, p<0.05)[32] had poor outcomes. The CPR was shown to be 149 
lower in cohorts with adverse perinatal outcomes compared to controls[29, 37] with two of these 150 
reaching significance[23, 27]. Four studies however did not demonstrate a significant association 151 
between low CPR and composite adverse perinatal outcome[11, 16, 29, 37]. 152 
Perinatal Mortality 153 
There were limited data reported for perinatal mortality. Morales-Rosello et al. 2014[15], reported 154 
six (0.05%) early neonatal deaths and six (0.05%) late neonatal deaths. The CPR data corresponding 155 
to these deaths however were not obtainable. Perinatal mortality was a component of one 156 
composite outcome score however no CPR data or mortality rates were obtainable from that study 157 
either[34]. 158 
 DISCUSSION 159 
This systematic review clearly demonstrates that a low CPR when detected at term is associated with 160 
a number of adverse obstetric and perinatal outcomes, regardless of birthweight. A low CPR is 161 
independently predictive of CS-IFC, SGA and FGR and NICU admission. Furthermore, a low CPR 162 
correlates significantly with pregnancies complicated by intrapartum events like MSL and FHR 163 
pattern abnormalities, as well as adverse neonatal outcomes, such as low Apgar scores and acidosis. 164 
Composite adverse perinatal outcomes were also significantly higher in low CPR cohorts. There were 165 
however no data related to the risk of perinatal mortality. This is probably because this is such a rare 166 
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event at term and the studies included in this systematic review were not powered to detect this 167 
outcome.  The results of this systematic review as well as other studies strongly support the 168 
incorporation of the CPR as a component in an antenatal screening test for adverse perinatal 169 
outcomes.  170 
There is considerable difficulty identifying pregnancies in which placental function is inadequate to 171 
support fetal growth potential and where greater risk of adverse perinatal outcomes exists. This 172 
clinical dilemma is particularly difficult in late pregnancy[41]. Current practices vary considerably but 173 
include symphysis-fundal height measurements, risk-based ultrasound assessment and routine third-174 
trimester ultrasound scan[42-45]. The conventional anthropometric model of EFW has high 175 
sensitivity for growth restriction, using the 10th centile as an arbitrary threshold. This biometric proxy 176 
for placental insufficiency however has a high false positive rate as it also includes healthy fetuses 177 
that may just be constitutionally small without being growth restricted[46]. Data also suggest this 178 
approach fails to identify AGA fetuses that, whilst above the 10th centile for EFW, have not reached 179 
their growth potential as a consequence of suboptimal placental function[15]. This cohort of 180 
pregnancies has been shown to have poorer perinatal outcomes than fetuses that have reached 181 
their growth potential[13]. Additionally, SGA fetuses may have subtle cardiovascular redistribution 182 
that is not appreciable with UA Doppler alone[28]. Other antenatal fetal surveillance tests in use like 183 
cardiotocography, amniotic fluid index and biophysical profile have not been shown to improve 184 
perinatal outcomes[47-51]. Thus, these limitations have largely prompted the renewed relevance of 185 
CPR as a potentially important clinical tool. 186 
The CPR was initially described in the 1980s[52] and assesses both placental function and fetal 187 
response by its evaluation of the UA and MCA Dopplers[52]. Current data suggest that it predicts 188 
adverse perinatal outcomes better than UA and MCA Dopplers on their own[18-23] and outperforms 189 
uterine artery Dopplers[53]. Conventional EFW by ultrasound performs relatively poorly at 190 
identifying at risk fetuses at term[54-59] and the CPR has been shown to better identify pregnancies 191 
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with adverse perinatal outcome than anthropometric models[13] and biophysical profile[19, 60]. 192 
The evaluation of CPR, particularly amongst SGA and FGR pregnancies, provides a strong predictor of 193 
adverse obstetric and perinatal outcomes: caesarean for intrapartum fetal compromise (CS-IFC) at 194 
term and acidaemia at birth[11, 17, 21, 32, 52, 61-64]. Furthermore, a low CPR has been associated 195 
with neurological morbidity in both growth restricted and AGA cohorts[12, 64-67].  196 
However, the majority of published studies report on the CPR evaluated in the mid and late 197 
trimesters pregnancy rather than at >37 weeks. Given that the majority of most pregnancies 198 
regardless of setting, proceed to term[68] and the difficulties in identifying late-pregnancy growth 199 
restriction and placental insufficiency, there is a clear need to improve the reliability of fetal 200 
surveillance techniques to predict adverse perinatal outcomes in this large cohort. Whilst the CPR 201 
has been suggested as a component of antepartum testing[69] there is a dearth of robust evidence 202 
from randomised clinical trials.  203 
Currently, there is increasing evidence from published studies as well as anecdotally that the CPR has 204 
been adopted into clinical decision making at term[41, 70, 71] despite the lack of good evidence 205 
supporting its use. One reason for this is that the optimal gestation at which to measure the CPR is 206 
not entirely apparent from the current evidence and some clinicians have extrapolated the data 207 
from preterm pregnancies to a term cohort. Most of the data available regarding the predictive 208 
ability of the CPR relate to cohorts of pre-term pregnancies complicated by growth restriction[61, 209 
72]. In a large prospective study of preterm SGA pregnancies, Flood et al. 2014[61], reported the 210 
sensitivity and specificity of CPR for adverse perinatal outcomes as 80-85% and 41-60% respectively. 211 
In other studies, despite the clear association with adverse obstetric and perinatal outcomes, 212 
detection rates are still relatively poor when measured <37 weeks[73, 74].  213 
In our view, incorporation of the CPR into routine clinical practice as a stand-alone measure of risk 214 
assessment is inappropriate for the following reasons.  Firstly, the optimal discriminatory threshold 215 
has not been definitively described and this will clearly impact upon detection rates for various 216 
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adverse outcomes. Although the CPR is significantly lower in pregnancies complicated by a number 217 
of adverse intrapartum and perinatal outcomes, there is substantial overlap between groups. The 218 
reported false positive rates in many of the studies are also unacceptably high and consideration 219 
needs to be given to the maternal and healthcare provider anxiety, a screen positive result would 220 
engender, in an otherwise “normal” pregnancy. Secondly, the optimal CPR-to-delivery interval is 221 
uncertain. Prior et al 2013[11] demonstrated an abnormal CPR measured within 72 hours of labour 222 
amongst an AGA cohort increased the likelihood of CS-IFC six-fold and conversely, a CPR >90th centile 223 
had a 100% NPV. The logistics of performing an ultrasound scan within this narrow window are 224 
largely impractical. More recent data though suggest that abnormal CPR measured up to two weeks 225 
remote from delivery yielded a ‘fair’ prediction for CS-IFC (AUROC 0.71), but not for an adverse 226 
neonatal composite outcome (AUROC 0.56)[14]. This time frame may be much more achievable 227 
particularly when aligned with a routine antenatal appointment. 228 
The ability of the CPR to identify the ‘at risk’ fetus might also be improved by combining it with other 229 
parameters. Addition of the CPR to the EFW improves the detection of FGR compared to EFW alone 230 
(DR 88.6% v 83.3%, 10% FPR) and the CPR, EFW and umbilical vein blood flow improved detection of 231 
adverse perinatal outcome compared to EFW alone (DR 29.2% v 19.2%, 10% FPR)[26] although 232 
overall detection rates are still poor. A number of maternal biochemical markers such as placental 233 
growth factor (PlGF) and soluble fms-like tyrosine kinase 1 have been linked to sequelae of placental 234 
dysfunction[75, 76]. There is evidence that PlGF is significantly lower in the final month of pregnancy 235 
in term, AGA pregnancies that went on to require emergency delivery for IFC and had poorer 236 
neonatal outcomes[77]. The inclusion of biochemical markers might therefore further strengthen 237 
the predictive utility of CPR.  238 
Of the publications included in this review, there were no randomised control trials and a substantial 239 
proportion of the data came from retrospective studies. Furthermore some of the outcomes 240 
reported in this systematic review may be considered “soft” endpoints that are not entirely relevant 241 
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in terms of longer term outcomes such as cerebral palsy. Hard outcomes such as perinatal death, 242 
meconium aspiration syndrome, hypoxic ischaemic encephalopathy and extended NICU admission 243 
however whilst perhaps more reflective of neonatal morbidity, require adequately powered and 244 
larger cohort studies. Whilst some studies did report these outcomes, the data were insufficient to 245 
establish an association with a low CPR.  246 
Nonetheless, despite these limitations the results presented in this systematic review strongly 247 
suggest that a low CPR is associated with a higher risk of obstetric intervention for intrapartum fetal 248 
compromise and poorer perinatal outcomes at term. In our view these results emphasise the need 249 
for randomised controlled trials to assess its value. 250 
  251 
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Table 2 – Association between low cerebroplacental ratio and obstetric and perinatal outcomes 
CPR – cerebroplacental ratio. *-p<0.05. NS – p>0.05. CS-IFC – caesarean for intrapartum fetal compromise. OP-IFC operative delivery for IFC. CS – caesarean. SVD spontaneous vaginal delivery. FHR fetal heart rate. MSL meconium stained 
liquor. BW- birthweight. NICU neonatal intensive care unit. CAPO composite adverse perinatal outcome.<5
th
 centile. <10
th
 centile. MoM Multiples of the median. 
a
 - 0.8095 MoM. 
b
 - 0.98.  
Outcome 
Bligh 
2016 
Bellido-
Gonzale
z 2016 
Triunfo 
2016 
Figueras 
2015 
Garcia-
Simon 
2015 
Khalil 
2015 
Morales
-Rosello 
2015 
Morales
-Rosello 
2015 
Prior 
2015 
Ropacka-
Lesiak 2015 
Maged 
2014 
Morales
-Rosello 
2014 
Prior 
2013 
D’Antonio 
2013 
Cruz-
Martine
z 2011 
El-
Sokkary 
2011 
Murata 
2011 
Gupta 
2006 
Lam 
2005 
Figueras 
2004 
Devine 
1994 
Low CPR 
≤1; 
<5
th
; 
<10
th
 
<5
th
 z-score <5
th
 <5
th
 
<0.6765 
MoM 
<5
th
 
a
; 
<0.6765 
MoM 
<0.6765 
MoM 
<0.6765 
MoM 
<1.1 ≤1.05 
<0.6765 
MoM 
<10
th
 
≤5
th b
; 
≤0.90 
<5
th
 <0.85 <1.1 <1.1; <1.3 ≤1.09  <1.05 
CS-IFC Yes*    
Yes 31.5% 
v 16.0%* 
   
Yes 
36.7% v 
11.3%* 
 
Yes 50.0% 
v 12.1%* 
 
Yes 
36.4% v 
9.5% v 
0%* 
 
Yes 
46.7% v 
22.0%* 
      
OP-IFC      
Yes 
13.1% v 
9.4%* 
               
CS  
Yes 
21.9% v 
11.1%* 
  
Yes 46.1% 
v 28%* 
    
Yes 24.6% v 
7.6%* 
    
Yes 
58.3% v 
29.3%* 
      
Less SVD         
Yes 
16.3% v 
37.9%* 
 
Yes 32.4% 
v 55%* 
 
Yes 
(CPR 
>90
%
) 
22.7% v 
44.9% v 
57.5%* 
        
Abnormal 
FHR 
Pattern 
        
Yes 
40.8% v 
18.5%* 
Yes 62.3% v 
19.0%* 
  
Yes 
86% v 
31% v 
12.5%* 
   
Yes 
1.05±0.
2 v 
1.23±0.
2*  
 
   
MSL         
Yes 
22.4% v 
11.4%* 
Yes 46.4% v 
24.1%* 
  
Yes 
22.7% v 
10.1% v 
2.5%* 
     
NS   
Lower BW 
or BW 
centile 
 Yes* Yes*  
Yes*; FGR 
49.4% v 
33.3%* 
 Yes*  Yes*  Yes*  
Yes*; SGA 
5.8% v 0%* 
 Yes* 
NS 
(BW); 
Yes* 
(centile) 
     
Yes*   
Apgar 
Score <7 
 No       
NS 
1min 
(26.1% v 
8.1%); 
5min 
(2.0% v 
1.2%) 
Yes 1min 
56.5% v 
5.1%*; 5min 
27.5% v 
1.3%* 
  
NS 
5min 
2.3% v 
0.9% v 
0% 
     
   
Acidosis at 
birth 
(arterial or 
venous) 
 No   
Yes 
(arterial 
<7.15 
11.2% v 
6.7%*) 
 
Yes* 
(venous 
pH) 
Yes* 
(arterial 
and 
venous 
pH) 
No 
Yes (arterial 
pH 39.1% v 
2.5%* & BE 
34.8% v 
5.1%*) 
  
NS 
pH<7.2: 
29.5% v 
28.5% v 
27.55% 
 Yes*    
 NS Yes* 
(arterial 
pO2) 
NICU  
Yes 
21.9% v 
11.1%* 
  
Yes 37.1% 
v 21.3%* 
Yes 
14.3% v 
9.7%* 
  
NS 2.0% 
v 1.8% 
   
NS 4.5% 
v 1% v 
2.5% 
     
   
CAPO    Yes Yes 57.3%    NS Yes 50.7% v Yes  No     NS   Yes 
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37.5% v 
19.1%* 
v 34.7%* 6.3%* 1.04±0.19 
v 
1.83±0.37
* 
1.23±0.13 
v 
1.39±0.26 
1.00 v 
1.20* 
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Table 3 – Predictive values of cerebroplacental ratio taken from 37+0 weeks gestational age 
CS-IFC caesarean for intrapartum fetal compromise. FHR fetal heart rate. MSL meconium stained liquor. NICU neonatal intensive care admission. CAPO 
composite adverse perinatal outcome. CPR – cerebroplacental ratio. MoM multiples of median. <10
th
 centile. <5
th
 centile. PPV positive predictive value. NPV 
negative predictive value. OD odds ratio. RR relative risk. LR likelihood ratio. DR detection rate. (95% CI) 95% confidence interval. aOR adjusted odds ratio. 
AUROC area under receiver operator characteristic curve.  
 
Outcome 
Low CPR 
Threshold 
Sensitivity Specificity PPV NPV OR/RR/LR/DR (95% CI) AUROC Reference 
CS-IFC 
<0.6765 MoM 
(10
th
 centile) 
18.0% 95.4% 36.7% 88.7% RR 3.25 (2.14-4.95)  Prior 2015 
<10
th
 32.5% 93.2% 36.4% 91.6% OR 6.1 (3.03-12.75) 0.69 Prior 2013 
<5
th
     
OR 10.3, (3.22-52.8) 
DR 45.9% (21.5% FPR) 
 Cruz-Martinez 2011 
<5
th
     OR 2.54 (1.18-5.61)  Garcia-Simon 2015 
MoM     
aOR 0.67 (0.52-0.87)* 
aOR 0.68 (0.52-0.91)† 
 Khalil 2015 
Abnormal 
FHR pattern 
<1.1 74.1% 71.1% 62.3% 81.0% LR 2.6  Ropacka-Lesiak 2015 
<1.1 62.5% 74.5% 45.5% 85.4%   Murata 2011 
<0.6765 MoM 
(10
th
) 
    RR 2.21 (1.53-3.20)  Prior 2015 
MSL 
<0.6765 MoM 
(10
th
)     
RR 1.96 (1.12-3.43  Prior 2015 
Birthweight z-score 
    
DR (10% FPR) SGA: 13.7, 
FGR: 27.8 
DR (20%) 
SGA: 0.56, 
FGR: 0.65 
Triunfo 2015 
Acidosis at 
birth 
<5
th
 
    
OR 5.0 (1.06-46.9) 
DR 37.5% (27.8% FPR) 
 Cruz-Martinez 2011 
NICU MoM  
    
aOR 0.55 (0.33-0.92)  Khalil 2015 
CAPO 
<1.1 87.8% 68.5% 51.4% 93.7% LR 2.8  Ropacka-Lesiak 2015 
z-score     DR 23.1 (10% FPR) 0.52 Triunfo 2016 
<1.05 80.0% 94.9% 80.0% 94.9%   Devine 1994 
<0.85 80.0% 72.0% 62.5% 77.0%   El-Sokkary 2011 
     2.43 (1.28-4.59)  Garcia-Simon 2015 
<1.1 40.0% 77.0% 25.0% 87.0%   Gupta 2006 
<1.3 80.0% 53.8% 25.0% 93.3%   Gupta 2006 
≤1.05 75.0% 98.2% 97.1% 83.3%  0.963 Maged 2014 
      0.53 D’Antonio 2013 
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Table 1 – Study characteristics 
AO adverse outcome. GA gestational age. CPR cerebroplacental ratio. Y Yes. P prospective. AGA appropriately grown. PI Pulsatility Index. <5
th
 centile. <10
th
 centile. R Retrospective. IUGR – Intrauterine growth restricted. SGA small for gestational 
age. NR not reported. LGA large for gestational age. MoM multiples of the median. 
a
 - 0.8095 MoM. RI resistance index. 
b
 - 0.98 MoM.    
Outcome 
Bligh 
2016 
Bellido-
Gonzalez 
2016 
Triunfo 
2016 
Figueras 
2015 
Garcia
-Simon 
2015 
Khalil 
2015 
Morales-
Rosello 
2015 
Morales-
Rosello 
2015 
Prior 
2015 
Ropacka
-Lesiak 
2015 
Maged 
2014 
Morales-
Rosello 
2014 
Prior 
2013 
D’Antonio 
2013 
Cruz-
Martinez 
2011 
El-
Sokkary 
2011 
Murata 
2011 
Gupta 
2006 
Lam 
2005 
Figueras 
2004 
Devine 
1994 
Significant 
association 
with AO 
Y Y Y Y Y Y Y Y Y Y Y Y Y N Y Y Y N Y N Y 
Study Type P R P P P R R R P R P R P R P P R P P P P 
GA 
36+0-
41+6 
≥37+0 37+1 ≥37+0 ≥37+0 ≥37+0 
37+0-
41+6 
37+0-
41+6 
37+0-
41+6 
40+0-
42+0 
40+0-
42+0 
37+0-
41+6 
37+0-
42+1 
≥41+3 ≥37+0 ≥40+0 
37+0-
41+6 
≥40+0 
≥41+
0 
41+0-
42+6 
≥41+0 
Cohort AGA IUGR All SGA SGA All All All AGA 
Post-
dates 
Post-
dates 
All AGA Post-dates SGA 
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Highlights 
• The cerebroplacental ratio (CPR) assesses both fetal and placental circulation  
• Low CPR at term is associated with adverse obstetric and perinatal outcomes 
• Predictive utility is inadequate as a stand-alone antenatal screening tool at term 
